Adverts

Open Access Articles- Top Results for AM-1248

AM-1248

</th></tr>
AM-1248
200px
Systematic (IUPAC) name
1-[(N-methylpiperidin-2-yl)methyl]-3-(adamant-1-oyl)indole
Clinical data
  • Temporary Class Drug (NZ)
Identifiers
335160-66-2 7pxN
PubChem CID 10293794
ChemSpider 8469262 7pxN
Chemical data
Formula C26H34N2O
390.561 g/mol
 14pxN (what is this?)  (verify)

AM-1248 is a drug that acts as a moderately potent agonist for both the cannabinoid receptors CB1 and CB2, but with some dispute between sources over its exact potency and selectivity. Replacing the 3-(1-naphthoyl) group found in many indole derived cannabinoid ligands, with an adamantoyl group, generally confers significant CB2 selectivity,[1] but reasonable CB1 affinity and selectivity is retained when an N-methylpiperidin-2-ylmethyl substitution is used at the indole 1-position.[2][3] The related compound 1-pentyl-3-(1-adamantoyl)indole was identified as having been sold as a cannabinoid designer drug in Hungary in 2011, along with another synthetic cannabinoid AM-679.[4]

See also

References

  1. ^ Frost, J. M. et al. (2010). "Indol-3-ylcycloalkyl Ketones: Effects of N1 Substituted Indole Side Chain Variations on CB2 Cannabinoid Receptor Activity". Journal of Medicinal Chemistry 53 (1): 295–315. PMID 19921781. doi:10.1021/jm901214q.  edit
  2. ^ US patent 7820144, Makriyannis A, Deng H, "Receptor selective cannabimimetic aminoalkylindoles", granted 2010-10-26 
  3. ^ WO patent 200128557, Makriyannis A, Deng H, "Cannabimimetic indole derivatives", granted 2001-06-07 
  4. ^ Jankovics P et al. (August 2011). "Detection and identification of the new potential synthetic cannabinoids 1-pentyl-3-(2-iodobenzoyl)indole and 1-pentyl-3-(1-adamantoyl)indole in seized bulk powders in Hungary". Forensic Science International 214 (1-3): 27–32. PMID 21813254. doi:10.1016/j.forsciint.2011.07.011. 


Lua error in package.lua at line 80: module 'Module:Buffer' not found.